News
-
-
PRESS RELEASE
EQS-Adhoc: Uniper SE: Uniper successfully closes the 2024 financial year with an Adjusted EBITDA of over EUR 2.6 billion and provides an outlook for the fiscal year 2025
Uniper SE successfully closes 2024 with Adjusted EBITDA of over EUR 2.6 billion, outlook for 2025 provided. Preliminary unaudited figures. Contact: Marc Merrill, Sebastian Veit, Georg Oppermann -
-
-
-
-
PRESS RELEASE
Healthcare specialist SHS Capital appoints Lukas Maucher to the Board of Managing Partners – Hubertus Leonhardt transitions to the Supervisory Board
SHS Capital appoints Lukas Maucher as Managing Partner, Hubertus Leonhardt transitions to Supervisory Board. Further growth secured with internal talent -
-
PRESS RELEASE
LINDIS BIOTECH AND PHARMANOVIA ANNOUNCE EUROPEAN MARKETING AUTHORISATION APPROVAL FOR CATUMAXOMAB, A FIRST-IN-CLASS TREATMENT FOR MALIGNANT ASCITES
Lindis Biotech and Pharmanovia receive European marketing authorisation approval for Catumaxomab, a first-in-class treatment for malignant ascites -